Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

BioNTech SE Sponsored ADR (BNTX) had Revenue of $1.37B for the most recently reported fiscal quarter, ending 2024-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2024-09-30

Income Statement Financials
Revenue	$1.37B
Net Income	$217.83M
Cost of Goods Sold	$196.72M
Gross Profit	$1.17B
Operating Expenses	$1.36B
Operating Income	$11.55M
Non-Operating Income/Expense	$162.96M
Pre-Tax Income	$174.51M
Normalized Pre-Tax Income	$174.51M
Income after Taxes	$217.83M
Income from Continuous Operations	$217.83M
Consolidated Net Income/Loss	$217.83M
Normalized Income after Taxes	$217.83M
EBIT	$11.55M
EBITDA	$62.37M
Weighted-Average Shares Outstanding (Basic)	241.59M
Weighted-Average Shares Outstanding (Diluted)	244.57M
Earnings per Share (EPS) (Basic)	$0.90
Earnings per Share (EPS) (Diluted)	$0.89
Balance Sheet Financials
Current Assets	$20.33B
Property, Plant, and Equipment	$1.01B
Long-Term Assets	$4.30B
Total Assets	$24.63B
Current Liabilities	$2.77B
Long-Term Debt	$226.85M
Long-Term Liabilities	$840.31M
Total Liabilities	$3.61B
Common Equity	$21.02B
Tangible Shareholders Equity	$19.65B
Shareholders Equity	$21.02B
Common Shares Outstanding	239.74M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$737.83M
Cash Flow from Investing Activities	$-2.96B
Cash Flow from Financial Activities	$-42.44M
Beginning Cash	$12.83B
End Cash	$10.58B
Increase/Decrease in Cash	$-2.24B
Stock-Based Compensation	$-72.79M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	7.33
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.01
Debt to Equity Ratio	0.01
Gross Margin	85.63%
Operating Margin	0.84%
EBIT Margin	0.84%
EBITDA Margin	--
Pre-Tax Profit Margin	12.75%
Profit Margin	15.91%
Free Cash Flow	$496.58M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.06
Inventory Turnover	0.59
Receiveable Turnover	1.04
Days Sales in Receivables	86.62
Return on Equity	1.04%
Return on Tangible Equity	1.11%
Return on Assets	0.88%
Return on Investments	1.03%
Book Value Per Share	$87.67
Free Cash Flow per Share	$2.03
Operating Cash Flow per Share	$3.02

Data from Zacks Investment Research, Inc.